Advertisement
Screener

AbCellera Biologics Inc. (ABCL) Material Contracts

AbCellera Biologics Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2024-08-06: Form 10-Q; Exhibit 10.2; Description Amended 2020 Share Option and Incentive Plan, and form of award agreement thereunder..
  • 2024-08-06: Form 10-Q; Exhibit 10.1; Description Seventh Amended and Restated Stock Option Plan, and form of award agreement thereunder..
  • 2024-02-20: Form 10-K; Exhibit 10.18; Description Strategic Innovation Fund Agreement between the Registrant and his Majesty the King in right of Canada as represented by the Minister of Industry, dated May 23, 2023..
  • 2024-02-20: Form 10-K; Exhibit 10.17; Description Contribution Agreement between the Registrant and his Majesty the King in right of the Province of British Columbia, as represented by the Ministry of Jobs, Economic Development and Innovation, dated May 23, 2023..
FiledFormExhibitDescription
2024-08-0610-Q10.2Amended 2020 Share Option and Incentive Plan, and form of award agreement thereunder.
2024-08-0610-Q10.1Seventh Amended and Restated Stock Option Plan, and form of award agreement thereunder.
2024-02-2010-K10.18Strategic Innovation Fund Agreement between the Registrant and his Majesty the King in right of Canada as represented by the Minister of Industry, dated May 23, 2023.
2024-02-2010-K10.17Contribution Agreement between the Registrant and his Majesty the King in right of the Province of British Columbia, as represented by the Ministry of Jobs, Economic Development and Innovation, dated May 23, 2023.
2023-11-0210-Q10.3Lease between Dayhu Investments (4th and Columbia) Ltd. and the Registrant.
2023-08-0310-Q10.2Strategic Innovation Fund Agreement between the Registrant and his Majesty the King in right of Canada as represented by the Minister of Industry, dated May 23, 2023.
2023-08-0310-Q10.1Contribution Agreement between the Registrant and his Majesty the King in right of the Province of British Columbia, as represented by the Ministry of Jobs, Economic Development and Innovation, dated May 23, 2023.
2022-07-198-K10.1Separation Agreement and Release between AbCellera Biologics Inc. and Neil Berkley

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47